These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity. Lim MS; Lemmert K; Enjeti A BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132 [TBL] [Abstract][Full Text] [Related]
6. Blastic plasmacytoid dendritic cell neoplasm or CD4+ CD56+ acute myeloid leukemia: A case report. Neji S; Lakhal FB; Salem SF; Ghali O; Neji HB; Achour M; El Borgi W; Gouider E Ann Biol Clin (Paris); 2024 Sep; 82(4):405-412. PubMed ID: 39210590 [TBL] [Abstract][Full Text] [Related]
7. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous lesion. Awasthi NP; Qayoom S; Dabadghao S J Cancer Res Ther; 2017; 13(6):1056-1058. PubMed ID: 29237977 [TBL] [Abstract][Full Text] [Related]
8. Blastic Plasmacytoid Dendritic Cell Neoplasm: The European Perspective. Deconinck E Hematol Oncol Clin North Am; 2020 Jun; 34(3):613-620. PubMed ID: 32336424 [TBL] [Abstract][Full Text] [Related]
9. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review. Ding Y; Yang J; Lindsey K Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088 [TBL] [Abstract][Full Text] [Related]
11. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face]. Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094 [TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm. Kharfan-Dabaja MA; Cherry M Hematol Oncol Clin North Am; 2020 Jun; 34(3):621-629. PubMed ID: 32336425 [TBL] [Abstract][Full Text] [Related]
13. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review. Paluri R; Nabell L; Borak S; Peker D Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172 [TBL] [Abstract][Full Text] [Related]
14. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy. Riaz W; Zhang L; Horna P; Sokol L Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209 [TBL] [Abstract][Full Text] [Related]
16. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148 [TBL] [Abstract][Full Text] [Related]
17. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review. Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199 [TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement. Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574 [TBL] [Abstract][Full Text] [Related]
19. Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report. Grushchak S; Joy C; Gray A; Opel D; Speiser J; Reserva J; Tung R; Smith SE Medicine (Baltimore); 2017 Dec; 96(51):e9452. PubMed ID: 29390581 [TBL] [Abstract][Full Text] [Related]
20. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia. Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]